Objective: Clostridioides difficile infection (CDI) remains a significant public health concern,
resulting in excess morbidity, mortality, and costs. Additional insight into the burden of CDI in …

Introduction Clostridioides difficile infection (CDI) is a major public health threat. Up to 40%
of patients with CDI experience recurrent CDI (rCDI), which is associated with increased …

Background Clostridioides difficile infection (CDI) is the most frequently reported nosocomial
infection. This study aimed to describe epidemiological trends, sex, race, and economic …

Background: One in four patients with primary Clostridioides difficile infection (CDI) develops
recurrent CDI (rCDI). With every recurrence, the chance of a subsequent CDI episode …

Background This real-world study assessed the epidemiology and clinical complications of
Clostridioides difficile infections (CDIs) and recurrences (rCDIs) in hospital and community …

Purpose Clostridioides difficile infection (CDI) is the leading cause of antibiotic-related
diarrhea and healthcare-associated infections, affecting in particular elderly patients and …

Objective: To describe 12-month outcomes for beneficiaries in the 100% Medicare Fee-for-
Service (FFS) population with primary and recurrent Clostridioides difficile infection (CDI) …

Clostridioides difficile (CD) is responsible for nosocomial diarrhea syndrome with possible
severe progression. Recurrence of the disease induces higher health system costs, as well …

Clostridium difficile infection (CDI) is one of the most common healthcare-associated
infections and an important cause of morbidity and mortality worldwide. The objective of the …

Clostridium difficile is the most common cause of hospital acquired infectious diarrhea in the
developed world and has re-emerged in recent years with apparent greater morbidity and …